期刊文献+

辛夷挥发油纳米脂质体的药理作用初探 被引量:10

Pharmacologic action of the Magnolia biondii Pamp volatile oil nanometer bangosome
下载PDF
导出
摘要 目的对辛夷挥发油纳米脂质体药理作用进行初步研究。方法通过观察辛夷挥发油纳米脂质体对小鼠耳肿胀、小鼠毛细血管渗出率和变应性鼻炎大鼠过敏症状的影响,对其药理作用进行初步研究。结果辛夷挥发油纳米脂质体能显著减轻二甲苯所致小鼠耳肿胀程度,能显著抑制醋酸所致的小鼠毛细血管通透性增加,并能有效对抗大鼠过敏性鼻炎所产生的鼻痒、喷嚏和流涕症状,疗效优于辛夷挥发油。结论辛夷挥发油纳米脂质体有较好的抗炎、抗过敏作用,采用纳米技术对传统辛夷进行加工可以显著提高其功效。 Objective To investigate the pharmacologic action of the Magnolia biondii Pamp volatile oil nanometcr bangosome. Methods The pharmacologic action of the Magnolia biondii Pamp volatile oil nanometer bangosome was evaluated by observing its effect on Jimpy mice with swelling ear, capillary permeability and rats with allergic symptoms. Results The Magnolia biondii Pamp volatile oil nanometer bangosome could significantly relieve the degree of swelling in Jimpy mice extended by p-xylene, inhibit the increased capillary permeability in Jimpy mice extended by HAC, and combat the symptoms of rhinocnesmus, sneezing, nasal discharge with a better effect than the Magnolia biondii Pamp volatile oil. Conclusion The Magnolia biondii Pamp Volatile oil nanometer bangosome has a good antiinflammation and anti-hypersensitiveness effect, which upgrades the effect of the Magnolia biondii Pamp volatile oil.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第4期392-394,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委纳米专项基金(0452nm057)~~
关键词 辛夷挥发油 纳米脂质体 耳肿胀 毛细血管渗出率 过敏性鼻炎 Magnolia biondii Pamp volatile oil nanometer bangosome swelling ear capillary permeability allergic rhinitis
  • 相关文献

参考文献13

二级参考文献48

  • 1高明海.纳米级粒径超微粒化通用装置[J].中国科教创新导刊,1997(1):47-43. 被引量:20
  • 2毕殿洲.药剂学,第4版[M].北京:人民卫生出版社,1999.211. 被引量:7
  • 3[1]Wright AL, Holberg C J, Martinez FD. Epidemiology of physician-diagnosed allergic rhinitis in childhood[ J ]. Pediatrics, 1994, 94(6 Pt 1):895-901. 被引量:1
  • 4[2]Mygind N, Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis[J]. Clin Exp Allergy, 1996, 26( Suppl 3): 2 - 10. 被引量:1
  • 5[3]Baraniuk JN, Meltzer EO, Spector SL. Putting together an effective plan for managing allergic rhinitis [ J]. J Respir Dis, 1996, 17(Suppl 8):S34-S44. 被引量:1
  • 6[4]Spector SL. Allergic and nonallergic rhinitis: update on pathophysiology and clinical management [ J ]. Am J Ther,1995, 2(2) :290- 295. 被引量:1
  • 7[5]Yap YG, Camm AJ. The current cardiac safety situation with antihistamines[ J] . Clin Exp Allergy, 1999, 29(Suppl 1):15-24. 被引量:1
  • 8[6]Nolen TM. Sedative effects of antihistamines: safety, performance, learning, and quality of life [ J ]. Clin Ther,1997, 19(1): 39 - 55. 被引量:1
  • 9[7]Mattila MJ, Paakkari I. Variations among non-sedating antihistamines: are there real differences[ J] ? Eur J Clin Pharmacol, 1999, 55(2):85-93. 被引量:1
  • 10[8]Gonzalez MA, Estes KS. Pharmacokinetic overview of oral second-generation H1 antihistamines[J]. Int J Clin Pharmacol Ther, 1998, 36(5) :292 - 300. 被引量:1

共引文献434

同被引文献193

引证文献10

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部